No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Ginseng (Panax ginseng, Panax quinquefolis)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance, a clinically significant interaction is unlikely. No effect on tenofovir-DF (the prodrug of tenofovir) is expected as Asian ginseng (Panax ginseng) had no significant effect on the pharmacokinetics of fexofenadine (a P-gp substrate). No interaction is expected with American ginseng (Panax quinquefolius).
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking